J Clin Neurol.  2019 Jul;15(3):308-312. 10.3988/jcn.2019.15.3.308.

Pattern of Extraocular Muscle Involvements in Miller Fisher Syndrome

• Ryu WY
• Kim YH
• Yoon BA
• Park HT
• Bae JS
• Kim JK

• KMID: 2451113
• DOI: http://doi.org/10.3988/jcn.2019.15.3.308

Abstract

BACKGROUND AND PURPOSE
The most-common initial manifestation of Miller Fisher syndrome (MFS) is diplopia due to acute ophthalmoplegia. However, few studies have focused on ocular motility findings in MFS. This study aimed to determine the pattern of extraocular muscle (EOM) paresis in MFS patients.
METHODS
We consecutively recruited MFS patients who presented with ophthalmoplegia between 2010 and 2015. The involved EOMs and the strabismus pattern in the primary position were analyzed. Antecedent infections, other involved cranial nerves, and laboratory findings were also reviewed. We compared the characteristics of the patients according to the severity of ophthalmoplegia between complete ophthalmoplegia (CO) and incomplete ophthalmoplegia (IO).
RESULTS
Twenty-five patients (15 males and 10 females) with bilateral ophthalmoplegia were included in the study. The most-involved and last-to-recover EOM was the lateral rectus muscle. CO and IO were observed in 11 and 14 patients, respectively. The patients were aged 59.0±18.4 years (mean±SD) in the CO group and 24.9±7.4 years in the IO group (p<0.01), and comprised 63.6% and 21.4% females, respectively (p=0.049). Elevated cerebrospinal fluid protein was identified in 60.0% of patients with CO and 7.7% of patients with IO (p=0.019) for a mean follow-up time from the initial symptom onset of 3.7 days.
CONCLUSIONS
The lateral rectus muscle is the most-involved and last-to-recover EOM in ophthalmoplegia. The CO patients were much older and were more likely to be female and have an elevation of cerebrospinal fluid protein than the IO patients.

Keyword

ophthalmoplegia; miller fisher syndrome; guillain-barré syndrome; GQ1b ganglioside

MeSH Terms

Cerebrospinal Fluid
Cranial Nerves
Diplopia
Female
Follow-Up Studies
Guillain-Barre Syndrome
Humans
Jupiter
Male
Miller Fisher Syndrome*
Ophthalmoplegia
Paresis
Strabismus

Reference

1. Snyder LA, Rismondo V, Miller NR. The Fisher variant of Guillain-Barré syndrome (Fisher syndrome). J Neuroophthalmol. 2009; 29:312–324. PMID: 19952907.

2. Yuki N, Odaka M, Hirata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology. 2001; 108:196–200. PMID: 11150289.

3. Lee SH, Lim GH, Kim JS, Oh SY, Kim JK, Cha JK, et al. Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody. Neurology. 2008; 71:426–429. PMID: 18678825.

4. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001; 56:1104–1106. PMID: 11320188.

5. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992; 31:677–679. PMID: 1514781.

6. Mizoguchi K. Anti-GQ1b IgG antibody activities related to the severity of Miller Fisher syndrome. Neurol Res. 1998; 20:617–624. PMID: 9785590.

7. Kim JK, Kim BJ, Shin HY, Shin KJ, Nam TS, Oh J, et al. Acute bulbar palsy as a variant of Guillain-Barré syndrome. Neurology. 2016; 86:742–747. PMID: 26718574.

8. Kim JK, Kim BJ, Shin HY, Shin KJ, Nam TS, Seok JI, et al. Does delayed facial involvement implicate a pattern of “descending reversible paralysis” in Fisher syndrome? Clin Neurol Neurosurg. 2015; 135:1–5. PMID: 26000550.

9. Chan JW. Optic neuritis in anti-GQ1b positive recurrent Miller Fisher syndrome. Br J Ophthalmol. 2003; 87:1185–1186. PMID: 12928295.

10. Ryu WY, Kim JK, Jin SW, Shim DH. Acute angle-closure glaucoma in a patient with Miller Fisher syndrome without pupillary dysfunction. J Glaucoma. 2015; 24:e5–e6. PMID: 25393040.

11. Wakerley BR, Uncini A, Yuki N. GBS Classification Group. GBS Classification Group. Guillain-Barré and Miller Fisher syndromes--new diagnostic classification. Nat Rev Neurol. 2014; 10:537–544. PMID: 25072194.

12. Keane JR. Bilateral ocular paralysis: analysis of 31 inpatients. Arch Neurol. 2007; 64:178–180. PMID: 17296832.

13. Thurtell MJ, Halmagyi GM. Complete ophthalmoplegia: an unusual sign of bilateral paramedian midbrain-thalamic infarction. Stroke. 2008; 39:1355–1357. PMID: 18309144.

14. Kim JK, Bae JS, Kim DS, Kusunoki S, Kim JE, Kim JS, et al. Prevalence of anti-ganglioside antibodies and their clinical correlates with Guillain-Barré syndrome in Korea: a nationwide multicenter study. J Clin Neurol. 2014; 10:94–100. PMID: 24829594.

15. Ahn J, Park KS, Kim JS, Hwang JM. Efficacy of gaze photographs in diagnosing ocular myasthenia gravis. J Clin Neurol. 2018; 14:333–338. PMID: 29856158.

16. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 1997; 745:32–36. PMID: 9037391.

17. Tan CY, Yuki N, Shahrizaila N. Delayed facial palsy in Miller Fisher syndrome. J Neurol Sci. 2015; 358:409–412. PMID: 26277343.

18. Tatsumoto M, Misawa S, Kokubun N, Sekiguchi Y, Hirata K, Kuwabara S, et al. Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes. Muscle Nerve. 2015; 51:811–814. PMID: 25287079.

19. Smith J, Clarke L, Severn P, Boyce R. Unilateral external ophthalmoplegia in Miller Fisher syndrome: case report. BMC Ophthalmol. 2007; 7:7. PMID: 17439660.

20. Susuki K, Yuki N, Muramatsu M, Hirata K. Unilateral ophthalmoparesis and limb ataxia associated with anti-GQ1b IgG antibody. J Neurol. 2000; 247:652–653. PMID: 11041338.